Skip to main content
The Maple Markets

Nasdaq · LTGO · ISIN US5179541033

Latigo Biotherapeutics Inc.

22.55 USD

1.38(5.77%)down

Previous close · Sep 18, 16:00 ET

Data last updated: (18 h ago)· Delayed exchange data

Sign in to add to portfolio

Latigo Biotherapeutics Inc. (LTGO) trades on Nasdaq and operates in the Medical - Pharmaceuticals industry. Its market capitalisation is approximately 1.36B USD. The company reports around 59 employees. Its ISIN is US5179541033. This page shows the latest available price, the day and 52-week ranges and an interactive chart. Quotes are delayed and are not intended for order execution.

Checking today's session…

Key facts

Exchange

Nasdaq

ISIN

US5179541033

Sector

Healthcare

Industry

Medical - Pharmaceuticals

Country

US

Market cap

1.36B USD

Employees

59

Previous close

23.93 USD

Day range

22.21 – 24.50

52-week range

17.22 – 25.93

Volume

1.49M

50-day average

21.77 USD

200-day average

21.77 USD

Asset type

Equity

About Latigo Biotherapeutics Inc.

Latigo Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its products include Molecule: LTG-001, Molecule: LTG-32, Molecule: LTG-001 IV and Molecule: LTG-418. The company was founded on November 20, 2018 and is headquartered in Thousand Oak, CA.

Company website

Frequently asked

+
What is the LTGO share price today?
This page shows the latest available Latigo Biotherapeutics Inc. (LTGO) price with its change against the prior close. Values are delayed or previous-close, not real-time.
+
Where is Latigo Biotherapeutics Inc. listed?
Latigo Biotherapeutics Inc. trades on Nasdaq under the symbol LTGO, ISIN US5179541033.
+
How large is Latigo Biotherapeutics Inc.?
Its market capitalisation is approximately 1.36B USD, based on the latest available price and share count from our data provider.

All Latigo Biotherapeutics Inc. data comes from exchange and provider feeds for Nasdaq and is published for information, not as investment advice.

Real-time quotes are not licensed; prices are delayed or previous close, so they may lag the market by 15 minutes or a full session. Information only, not for trading. Where a figure is not covered by our licensed sources, the page says so rather than showing a substitute.

We use necessary cookies to run the site and, only with your permission, analytics cookies to understand what readers use. Cookie policy